Thirona teams up with Smart Reporting to further improve COVID-19 detection
Combining image analysis with structured reporting, the software aims to improve and accelerate the detection of the virus
Combining image analysis with structured reporting, the software aims to improve and accelerate the detection of the virus
Atomwise provides rapid and cost-effective compound screening to address pharmaceutical R&D productivity
Avacta and Liverpool School of Tropical Medicine collaborate to clinically validate saliva-based rapid coronavirus test being developed with Cytiva
A University of Bern international research team has succeeded in developing an electrocatalyst for hydrogen fuel cells
Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%
First participants dosed in trial of AZD7442 to assess safety, tolerability and pharmacokinetics of the combination
Supports cross-functional teams of chemists and biologists developing non-natural, chemically modified therapeutics for drug discovery
Researchers at the University of Bern have now discovered which genes play an important role in the response to radiation therapy
A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK as early as autumn, thanks to a £1.9million award from the UK government
The overall goal is to continue to detect and discover critical components in the overall cellular response to COVID-19
QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing, whereas QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research
Across all populations, BNT162b2 administration was well tolerated with mild to moderate fever in fewer than 20% of the participants